Evaluation of Procalcitonin (PCT) as a Marker of Infection Post Living Donated Liver Transplant

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 15, 2018

Primary Completion Date

December 20, 2018

Study Completion Date

February 10, 2019

Conditions

Liver Transplant Infection

Interventions

DIAGNOSTIC_TEST

procalcitonin

assessing the frequency of rising procalcitonin associated with infectious complications in immunosuppressed LDLTRx.

Trial Locations (1)

NHTMRI, Cairo

All Listed Sponsors

lead

National Hepatology & Tropical Medicine Research Institute

OTHER_GOV

NCT03389360 - Evaluation of Procalcitonin (PCT) as a Marker of Infection Post Living Donated Liver Transplant | Biotech Hunter | Biotech Hunter